Spain · AEMPS CIMA
EXELON 13,3 mg/24 H PARCHE TRANSDERMICO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 198066029
- Form
- PARCHE TRANSDÉRMICO
- Composition / generic term
- rivastigmina
- Source strength
- 27MG RIVASTIGMINA/PARCHE LIBERANDO 13,3 MG EN 24 H
- Authorisation holder
- Novartis Europharm Limited
- Marketed in source snapshot
- Yes
Source-listed ingredients
- RIVASTIGMINA — 27 mg
These values do not establish equivalence or a dose recommendation.
Packages
- EXELON 13,3 mg/24 H PARCHE TRANSDERMICO 60 sobres
- EXELON 13,3 mg/24 H PARCHE TRANSDERMICO 60 (2 x 30) parches
Source and coverage
- Professional information (original source)
- Patient leaflet (original source)
- Official document (original source)
Snapshot retrieved: 2026-09-18. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Spain records →